Zerigo Health Appoints Helen Calvin as President and Chief Commercial Officer

Zerigo Health, a Serra Capital III portfolio company, announced this week that it has appoint Helen Calvin as the new President and CCO. Helen brings 15+ years of experience in scaling companies across digital health.

Zerigo Health offers the only comprehensive home solution that seamlessly connects patients and providers to deliver optimal dermatological outcomes. Zerigo’s precision solution remotely treats and monitors patients with chronic skin conditions using narrowband ultraviolet B (NB-UVB) phototherapy, a proven, standard-of-care treatment. Patients benefit from the unique combination of advanced technology with personal coaching and support throughout their treatment journey, which results in documented increases in treatment adherence and patient satisfaction. To learn more, visit www.zerigohealth.com.